Peter Greenleaf, CEO at Sucampo Pharmaceuticals, holds 0.00 shares in Sucampo Pharmaceuticals (Ticker: SCMP), holds ― shares in Synlogic (Ticker: SYBX), holds ― shares in Cerecor Inc (Ticker: CERCU).
Peter Greenleaf latest transaction was an Uninformative Sell of $2.34M.
What was Peter Greenleaf's most profitable transaction?
Peter Greenleaf’s most profitable transaction was an Informative Buy of AVTX stock on May 21, 2018. The return on the trade was 41.30%.
What is Peter Greenleaf's role in Sucampo Pharmaceuticals?
Peter Greenleaf's role in Sucampo Pharmaceuticals is CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.